The WHO ruled that CBD is not addictive, not harmful to health and has potential therapeutic properties.
The World Health Organisation (WHO), UN body, determined that cannabidiol (CBD), a non-psychoactive molecule from the cannabis Sativa L. plant, is not a dangerous substance but, on the contrary, has a high potential therapeutic.
At the beginning of 2019, the WHO had announced that after 82 years, the Expert Committee on Drug Dependence would conduct a specific review of the medical evidence on CBD.
The report reported on the conclusions reached by the experts after reviewing the existing literature on a drug that occupies a place in Schedule I of globally banned substances.
The most important conclusion reached by experts from the international community is the recognition of significant health benefits and the non-dangerousness of this cannabinoid currently used for multiple medical treatments.
The report's comments come in different directions. On the first level, the report talks about the lack of dependence.
The second aspect concluded that there is no individual or social abuse due to misuse of the substance. There were also no reported trafficking problems in countries. "There are no reported cases of abuse or dependence from the use of pure CBD. There are no known public health concerns, such as driving under the influence of the substance.". The clinical and pre-clinical studies on the substance were also acknowledged. "The CBD has been investigated for a variety of conditions such as the epilepsy This is the area where most progress has been made".
"There is preliminary evidence that the CBD may be effective in the treatment of Alzheimer's, Cancer, Psychosis, Parkinson and others. Finally, the WHO makes a recommendation on the possibility of removing CBD from the current classification.
"Based on the evidence, CBD lacks psychoactivity, has reinforcing properties and is not prone to abuse. On the other hand, emerging studies suggest high therapeutic promise. Declassifying this substance could impact on accessibility and scientific research.".
Summary of the WHO Report on CBD:
The results of this report could have a positive impact on access and contribute to legislative change in countries where patients are now becoming aware. Especially if the recommendations of the World Health Organisation are taken up within the US federal ban.
Many countries around the world have accepted the uses of CBD. in health programmes, particularly for patients with epilepsy. The report does not touch on the issue of the known psychoactive component THC.
1. CBD is not addictive or harmful to healthAnimal studies report that no tolerance has been identified and no studies have been reported indicating physical dependence. The opposite effect has been identified. High doses do not affect the increase in dopamine release. Regarding the consequences of the potential abuse of this cannabinoid, according to the intracranial stimulation analysed in mice, no adverse effects of CBD abuse have been found. Medical studies in humans show that CBD is as addictive as placebo. And that cannabidiol alone does not produce any significant psychoactive or cardiovascular effects. They also conclude that CBD does not produce any negative consequences of abuse.
2. It does not cause social alarmIn the second point of the WHO report, it is acknowledged that no public concerns about CBD use or accidents related to CBD have been identified. CBD has potential as a medicinal substance. The report notes that a number of advanced research studies have demonstrated its effectiveness against epilepsy and attach a list of other ailments for which CBD could be useful.
This is the first time in history that a UN organisation has recognised the therapeutic properties of cannabis.